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sociated, and plasminogen was nonsignificantly inversely 
associated with subclinical radiographic infarct. Further 
studies on the role of these hemostatic factors in the devel-
opment of silent lacunar infarcts may help elucidate the 
mechanisms behind this injury and may even point to poten-
tial targets for future intervention. 
 Copyright © 2009 S. Karger AG, Basel 
 Hemostatic mechanisms are rarely considered in most 
stroke patients, despite the key role of hemostatic factors 
in thrombus formation. Hypercoagulable states may be 
assessed in young patients with cryptogenic stroke, or 
hyperviscosity may be considered in individuals with 
polycythemia vera and ischemic stroke. Hemostatic fac-
tors play different roles in thrombus formation and break-
down, and the balance between these factors is likely to 
be critical in the etiology of diseases related to thrombo-
sis or embolism. Von Willebrand factor (vWF), an endo-
thelial cell product and marker of endothelial cell func-
tion, is a key factor in arterial thrombosis, mediating 
platelet adhesion to sites of vascular injury.   -Thrombo-
globulin (  -TG) is a specific marker of platelet activation. 
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 Abstract 
 Background: Previous data are conflicting as to whether im-
balance between hemostatic factors is associated with clini-
cal strokes. We evaluated the association between hemo-
static factor levels and  subclinical lacunar infarcts in a nested 
sample from a subset of the Atherosclerosis Risk in Commu-
nities (ARIC) cohort.  Methods: 196 cases without clinical 
strokes had lacunar infarcts by MRI, and 214 controls with-
out radiographic infarcts were frequency-matched by age 
group and sex. Logistic regression models were fitted to as-
sess the association between levels of hemostatic markers 
and case status.  Results: In age-, race- and sex-adjusted 
models, von Willebrand factor (vWF) and D-dimer were pos-
itively associated with case status, with odds ratios for the 
highest vs. lowest tertile of 2.0 (95% CI 1.2–3.6) for vWF and 
1.76 (95% CI 1.02–3.0) for D-dimer. Plasminogen had nonsig-
nificant inverse associations with presence of silent lacunar 
infarcts.  Conclusions: vWF and D-dimer were positively as-
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Factors involved in the endogenous fibrinolytic process 
are also critical in determining likelihood of thrombus 
formation. D-dimer, a marker of active fibrinolysis, may 
consequently also be an index of elevated levels of depos-
ited fibrin. Low or impaired fibrinolysis may allow for 
progression of thrombus.
 The Atherosclerosis Risk in Communities (ARIC) 
study is a biethnic prospective cohort of 15,792 individu-
als from four centers. In ARIC, fibrinogen, factor VIIIc, 
vWF, and white blood cell count were positively associ-
ated with incident ischemic stroke after adjustment for 
established vascular risk factors. The adjusted relative 
risk for vWF in the highest quartile compared to the low-
est quartile was 1.71 (95% CI 1.1–2.7)  [1] . Fibrinogen and 
vWF levels were positively associated with asymptomatic 
carotid disease  [2] , as were plasminogen activator inhibi-
tor-1 (PAI-1) antigen, tissue plasminogen activator (tPA) 
antigen, and D-dimer levels  [3] . vWF and fibrinogen were 
positively associated with MRI-detected infarcts  [4] .
 Fisher  [5, 6] described the histology of lacunar strokes 
as due to lipohyalinosis and thrombosis of the penetrat-
ing branches of the cerebral arteries. Thus, if these small 
vessels are more prone to occlusion by thrombosis than 
larger vessels, then any factors that increase the likeli-
hood of thrombosis might preferentially increase the risk 
of small strokes. The purpose of the current study was to 
determine if hemostatic and related markers from a more 
extensive battery added to prediction of  subclinical lacu-
nar infarction in a nested sample of the ARIC cohort.
 Methods 
 Study Population 
 The ARIC cohort includes 15,792 individuals who were 45–64 
years of age at a baseline examination in 1987–1989. These indi-
viduals reside in Forsyth County, N.C., Jackson, Miss. (African-
Americans only), Minneapolis, Minn., or Washington County, 
Md., USA. A subgroup of this larger cohort received research MRI 
scans, and a further subset of that group, without history of clin-
ical stroke, comprised the cases and controls for this analysis. The 
ARIC Study has been approved by all participating institutional 
review boards.
 For this particular study, only those persons who also under-
went brain MRI at the third ARIC examination in 1993–1995 
were included for analysis. At that time 2,825 persons,  6 56 years 
of age, from Forsyth County or Jackson were invited for MRI. 2% 
of women and 6% of men had contraindications for MRI, 28% of 
participants refused the examination, and 1,949 individuals were 
imaged. Images were of sufficient quality for grading of 1,920 ex-
aminations.
 Among those who had research MRI scans, a total of 237 in-
farcts (cases; infarct definition described below) were found, and 
for comparison a subset (controls, n = 227) of those with MRI data 
and not meeting the case definition (not having radiographic in-
farcts) were selected with frequency matching by sex and age 
group. After excluding persons with missing hemostasis values, 
persons known to have taken anticoagulation medications at the 
baseline examination or at the third ARIC examination, or who 
had been diagnosed with clinical stroke prior to the MRI (15 cas-
es and 6 controls), 196 cases, with subclinical infarcts, and 214 
controls, similar but without subclinical infarcts, remained for 
analysis ( table 1 ). Because we excluded both cases and controls 
with clinical stroke, the infarcts identified on the cases’ MRI 
scans were believed to be consistent with subclinical infarction.
 MRI and Determination of Stroke Type 
 The MR scanning protocol has been described in detail  [7] . 
Participants were scanned on 1.5-tesla scanners. Infarct rating 
was assigned by trained readers at the ARIC MR Reading Center 
at Johns Hopkins Medical Institutions in Baltimore. Primary im-
age reviewers were board-certified radiologists with subspecialty 
training in neuroradiology who were blinded to any clinical or 
demographic information. Infarcts were defined as abnormal sig-
nal intensity in a vascular distribution without mass effect. In-
farcts were hyperintense to gray matter on both spin density and 
T 2 -weighted images, and lesions in white matter had to also be 
hypointense on T 1 -weighted images, with intensities similar to 
cerebrospinal fluid. Using previously established criteria, we ana-
lyzed lacunar infarcts, which were defined as being between
3 mm (smaller abnormalities could not be reliably detected) and 
20 mm in maximum diameter  [8, 9] .
 Measurement of Hemostatic Factors 
 Blood was drawn using a standardized protocol at the third 
ARIC visit (1993–1995). Plasma was separated at 4 ° C and stored 
at –70 ° C until assayed for hemostatic factors. Methods used by 
the ARIC hemostasis laboratory for D-dimer, tPA antigen, plas-
minogen, PAI-1 antigen  [10] , fibrinogen and vWF  [1] , soluble 
thrombomodulin  [11] , C-reactive protein  [12] , and   -TG  [13] as-
says have been described. Reliability coefficients (based on re-
peated measurements in samples from individuals taken over a 
few weeks) were 0.83 and 0.81 for   -TG and tPA, respectively; D-
dimer, PAI-1, and fibrinogen were intermediate at 0.73, 0.72, and 
0.72, respectively  [14, 15] , and reliability was 0.70 for plasminogen 
and 0.68 for vWF  [10, 16] . For soluble thrombomodulin, the Pear-
Table 1. Exclusions of cases with MRI-detected infarcts and 
matched controls, ARIC participants aged ≥56 years with cere-





Missing hemostasis values 13 5
Used anticoagulation at visit 1 (1987–89) 7 1
Used anticoagulation at visit 3 (1993–95) 6 1
Had clinical stroke prior to MRI 15 6
Total included 196 214
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son correlation coefficient between the duplicate samples from 
the same participant was 0.85 (n = 64 pairs), the within-pair SD 
was 14.83, and the within-pair coefficient of variation was 0.314 
 [17] . The Pearson correlation coefficient for C-reactive protein 
was 0.96  [12] .
 Data Analysis 
 SAS 9.1 was used for primary analyses, and SUDAAN 9.0 was 
used for the weighted analyses. The sample is a stratified random 
sample of the ARIC cohort, with one stratum for cases with sam-
pling fraction equal to 1.0, and four strata of controls, based on 
sex and age group, with varying sampling fractions. Sampling 
weights were the inverse of the sampling fractions. For descriptive 
statistics, including tertiles of the hemostasis variable distribu-
tions, sampling weights were applied and statistical tests apply 
methods appropriate to stratified random samples. Unweighted 
logistic regression models were fit, accounting for the sampling 
by always adjusting for age, race, and sex, and subsequently with 
further adjustment for stroke risk factors (current smoker, diabe-
tes, left ventricular hypertrophy (LVH) by electrocardiogram, 
previous myocardial infarction, coronary artery disease, use of 
antihypertensive medications, and systolic blood pressure at visit 
3). Because of recognized differences in levels of some hemostatic 
factors in blacks versus whites  [2] , analyses were repeated post-
hoc separately by race.
 Results 
 The study includes 196 cases with silent MRI infarcts 
and 214 age- and sex-matched controls. Cases had higher 
systolic blood pressure and were more likely to be black, 
to be smokers, and to take antihypertensive medications 
( table 2 ). The weighted median, lower, and upper tertile 
values for each of the hemostatic variables tested are dis-
played in  table 3 . Weighted median (and mean) levels of 
vWF, fibrinogen, D-dimer, and   -TG were higher in cas-
es than controls.
 In models including only one hemostatic variable at a 
time (not shown), the odds ratios (OR) for case status for 
vWF levels in the highest vs. the lowest tertile were 2.04, 
95% CI 1.18–3.55 after age, race and sex adjustment and 
1.74, 95% CI 0.96–3.15 in fully adjusted models (covari-
ates as listed in  table 4 ). Similar analysis showed D-dimer 
associated with case status (age/sex/race-adjusted OR 
1.76, 95% CI 1.02, 3.02; fully adjusted OR 1.48, 95% CI 
0.82, 2.67). Plasminogen had an inverse although nonsig-
nificant and lacking dose-response association in both 
models (demographic-adjusted OR 0.78, 95% CI 0.46, 
1.32; fully adjusted OR 0.69, 95% CI 0.39, 1.22, comparing 
highest tertile to lowest tertile).
 These relationships persisted in models including two 
hemostatic variables together, demonstrating positive as-
sociations with higher values of vWF and D-dimer and 
inverse associations with higher levels of plasminogen. 
The associations with vWF and D-dimer were stronger 
after accounting for plasminogen. These results are dis-
played in  table 4 , including models with both demo-
graphic adjustments and demographic plus risk factor 
adjustments.
 Although univariate associations were significant for 
several hemostatic variables ( table 3 ), neither fibrinogen 
nor   -TG remained significant in adjusted models. How-
ever, the addition of the combination of vWF and plas-
Table 2. Vascular risk factors in cases with MRI-detected infarcts and matched controls
Cases (n = 196) Controls (n = 214) p value*
Age, years 64.4 62.5 (matched)
Sex, % male 38.8 40.2 (matched)
Race, % black 62.8 43.8 <0.001
Systolic blood pressure, mm Hg                             135                               125 <0.001
On antihypertensives, % 57.8 31.9 <0.001
Current smoking, % 27.2 14.3 0.003
Prevalent CHD, % at visit 3 7.3 5.4 0.449
Diabetes, %, fasting glucose >126 mg/dl 23.2 16.8 0.130
LVH by ECG, % 5.3 3.9 0.497
Self-reported aspirin use in past 4 weeks, % 49.5 44.0 0.285
Statin use in past 2 weeks, % 4.1 5.9 0.416
* For categorical variables, weighted unadjusted proportions are presented. For continuous variables, weight-
ed unadjusted means are presented. p values are calculated in SUDAAN respecting the stratified random sam-
ple design.
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minogen to the fully adjusted model with risk factors ( ta-
ble 4 , model B) was significant (–2 log likelihood differ-
ence = 12.23 (  2 ), 4 d.f., p = 0.016). The addition of 
plasminogen and D-dimer to the adjusted model with 
risk factors ( table 4 , model D) also added significantly to 
the model (  2 = 16.57, 4 d.f., p = 0.002).
 Similar associations were observed in blacks and 
whites studied separately (not shown in tables), although 
point estimates for vWF in the models with plasminogen 
were generally higher in blacks, with decreased power 
due to smaller sample sizes in these separate groups 
(model A, 2nd (middle) vs. 1st (lowest) tertile, OR 2.17 
(0.93, 5.08), 3rd (highest) vs. 1st (lowest) tertile, 2.61 (1.18, 
5.75)) than in whites (2nd vs. 1st tertile, OR 1.05 (0.49, 
2.27), 3rd vs. 1st tertile: 2.25 (0.98, 5.20)). For model B, 
point estimates for the association between vWF and case 
status were higher for blacks in both tertile comparisons 
than for whites. Mean (and median) levels of vWF, D-di-
mer and plasminogen were all higher in blacks than in 
whites, for both cases and controls.
 Conclusions 
 vWF and D-dimer were positively associated, and 
plasminogen was nonsignificantly inversely associated 
with subclinical radiographic infarct. These results are 
similar to the associations of vWF previously reported 
Table 3. Weighted medians and tertiles of the hemostasis variables, and p values for tests for differences between 
cases and controls for medians
Hemostatic factor Cases, median (lower, 
upper tertile cut points)
Controls, median (lower,
upper tertile cut points)
p value
vWF, % 148 (130, 169) 133 (107, 147) 0.01
Fibrinogen, mg/dl 360 (326, 389) 343 (313, 379) 0.05
Plasminogen, % 111 (105, 120) 113 (107, 119) 0.63
D-dimer, ng/ml 449 (365, 555) 378 (278, 448) 0.004
-TG, ng/ml 18.6 (14.4, 24.0) 15.4 (13.8, 18.5) 0.002
TPA antigen, ng/ml 9.96 (7.96, 13.11) 9.11 (7.46, 11.66) 0.16
PAI-1 antigen, ng/ml 16.4 (10.4, 25.0) 16.2 (10.6, 25.0) 0.90
C-reactive protein, mg/dl 3.17 (1.84, 5.51) 2.55 (1.20, 4.54) 0.27
Soluble thrombomodulin, ng/ml 27.2 (23.2, 34.7) 29.4 (22.9, 36.2) 0.25
Table 4. Adjusted ORs of 2nd and 3rd tertile values of hemostatic factors (vWF, plasminogen, D-dimer) for ra-
diographically present cerebral infarcts (with 95% CIs), in models with combined pairs of hemostatic factors in 
addition to other variables for adjustment
Model A* Model B** Model C* Model D**
vWF
2nd vs. 1st tertile 1.4 (0.8, 2.5) 1.4 (0.8, 2.6)
3rd vs. 1st tertile 2.2 (1.2, 3.8) 1.9 (1.0, 3.4)
Plasminogen
2nd vs. 1st tertile 0.5 (0.3, 0.8) 0.4 (0.2, 0.8) 0.5 (0.3, 0.8) 0.4 (0.2, 0.7)
3rd vs. 1st tertile 0.7 (0.4, 1.2) 0.6 (0.4, 1.2) 0.7 (0.4, 1.2) 0.6 (0.4, 1.2)
D-dimer
2nd vs. 1st tertile 1.4 (0.8, 2.3) 1.1 (0.6, 2.1)
3rd vs. 1st tertile 1.9 (1.1, 3.3) 1.6 (0.9, 2.9)
* Adjusted for age, race, and sex.
** Adjusted for age, race, sex, current smoking, diabetes, LVH by ECG, previous MI, coronary artery disease, 
use of antihypertensives, systolic blood pressure.
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with clinical stroke, other MRI abnormalities  [4] , and of 
both vWF and D-dimer with peripheral arterial disease 
 [18] . In addition, our analysis includes additional results 
with a more extensive panel of hemostatic and inflamma-
tory factors. Our findings, in combination with these and 
other previous observations, emphasize the potential im-
portance of hemostatic abnormalities in the development 
of both clinical and subclinical vascular disease of the 
brain; thus, similar preventive strategies may be effec-
tive.
 The growing body of evidence supporting the impor-
tance of factors such as vWF, plasminogen and D-dimer 
in stroke prediction may point to a potential future target 
in the prevention of stroke or of subclinical stroke. Sev-
eral of these markers are not only hemostatic in mecha-
nism, but are potential markers of endothelial dysfunc-
tion (vWF) or inflammation (fibrinogen), which may 
further support a clinically relevant mechanism. In a 
study in swine, the specific use of a monoclonal antibody 
to vWF, for example, led to an 81% reduction in platelet 
deposition on de-endothelialized vessel wall, when com-
pared with a 30% reduction from aspirin  [19] . More in-
vestigation is needed in this area.
 Results similar to ours were found in a Japanese group 
of 123 asymptomatic hypertensive subjects  1 55 years of 
age, where clinically silent infarcts detected by MRI were 
associated with elevated levels of PAI-1, D-dimer, and 
vWF. In that study all subclinical infarcts were lacunar 
infarcts of  ! 15 mm in diameter  [20] . This association of 
hemostatic factors with smaller lacunar infarcts is con-
sistent with pathologic theories of lacunar infarction. Al-
though the purpose of the hemostatic system is to prevent 
excessive blood loss in the event of injury to a blood ves-
sel, this process can become pathologic and lead to throm-
bosis and vessel occlusion. This may be particularly con-
cerning in smaller-sized vessels, as the smaller caliber of 
these vessels may make them more easily blocked by 
thrombus or emboli. This potential preference of hemo-
static factors for lacunar infarction was not supported, 
however, in one study in which individuals with lacunar 
versus cortical strokes did not differ in levels of endoge-
nous fibrinolytic factors, PAI-1 and tPA in blood drawn 
within 7 days following the stroke  [21] .
 Knowledge of hemostatic abnormalities is useful not 
only for understanding the pathogenesis of small vessel 
infarction, but potentially also for evaluating overall 
stroke risk. Recent reports of stroke prediction have con-
centrated on not only the ‘traditional’ risk factors but 
have expanded to include nontraditional risk factors, in-
cluding hemostatic factors. Hemostatic markers may help 
in predicting both stroke and outcome among patients 
with clinical stroke. Elevated levels of vWF and   -TG 
were associated with higher mortality among subjects 
with history of clinical stroke  [22] . Many prospective co-
hort studies have shown increased rates of stroke and 
other cardiovascular disease in individuals with elevated 
levels of certain markers of hemostasis. In the Caerphilly 
cohort of over 2,000 men in Scotland, traditional risk fac-
tors were associated with a hazard ratio for cardiovascu-
lar disease of 2.7 when top and bottom tertiles of the pre-
diction score were compared, but addition of four hemo-
static factors (PAI-1, fibrinogen, D-dimer, and factor 
VIIc) increased the hazard ratio of the prediction score to 
3.7. Three of these hemostatic factors (PAI-1, D-dimer, 
and thrombin-antithrombin complexes) were also stron-
ger predictors of ischemic stroke (e.g. HR 2.25 for D-di-
mer) than of coronary heart disease (HR 1.03 for highest 
levels)  [23] . Fibrinogen was both a univariate predictor of 
ischemic stroke and remained significant after multivar-
iate adjustment in the Edinburgh Artery study, as did tPA 
and D-dimer  [24] . The addition of markers of endothe-
lial cell dysfunction, such as vWF, when added to clinical 
stroke risk calculation have been noted to improve pre-
diction of risk of subsequent stroke in moderate risk pa-
tients  [25] .
 One limitation of our study is the cross-sectional de-
sign. It is possible, though perhaps unlikely, given the 
small size of the silent infarcts studied, that the cerebral 
infarction itself may have affected our measures of sys-
temic hemostasis, and not vice versa. Given the cross-sec-
tional design, the direction of the relationship cannot be 
determined. Another limitation of the case-control de-
sign is that there may have been other unmeasured con-
founders, which could be associated both with elevated 
vWF, for instance (likely reflecting endothelial activa-
tion), and with silent cerebral infarction. We did not ex-
clude individuals on antiplatelet medications, since this 
would have dramatically reduced the sample size, but it 
is possible that the use of antiplatelet medications could 
also confound the results. Our sample size was relatively 
small, with sufficient power to detect only the most mod-
erate associations. Generally, the associations were mod-
est, and in multivariate models many of the associations 
lost statistical significance. Finally, the fact that hemo-
static factors used were measured at a single time point 
with only moderate reliability may have limited the 
strength of our study.
 Despite these limitations, the findings support a pos-
sible role for hemostatic factors in subclinical cerebral 
ischemia. The study is strengthened, however, by the bi-
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ethnic distribution of its cohort, allowing analysis which 
showed similar associations by race. This is particularly 
important because black and white participants have dif-
ferent levels of hemostatic factors. The study is also 
strengthened by the broad panel of hemostatic factors 
measured and the standardized definition of radiograph-
ic infarct.
 Silent brain infarcts were modestly associated in this 
study with higher levels of vWF and D-dimer and with 
lower levels of plasminogen. Further studies on the role 
of these and other hemostatic factors in the development 
of silent infarcts and white matter ischemic disease may 
help elucidate the mechanisms behind this injury and 
may even point to potential targets for future interven-
tion in stroke prevention.
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